Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016
Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …

News
AS spine fusion

Novartis’ Cosentyx shows benefits in Phase III AS trials

January 4, 2016
Research and Development, Sales and Marketing Cosentyx, Novartis, Secukinumab, ankylosing spondylitis

Novartis says results from two Phase III studies for Cosentyx in ankylosing spondylitis (AS) showing significant clinical improvements versus placebo.Results …

News
Gilenya

EMA adds warning label to Novartis’ MS treatment Gilenya

December 22, 2015
Manufacturing and Production EMA, European Medicines Agency, FDA, Novartis, PML, basal cell carcinoma, fingolimod, gilenya

Drug safety regulators in Europe have said they will add warnings to the label and prescribing information of Gilenya (fingolimod), …

News
csm_297_1444449899_5ce719038f

US ‘star’ Bradner to head Novartis Institute of Biomedical Research

December 17, 2015
Research and Development James Bradner, Jay Bradner, Mark Fishman, Novartis, Novartis Institute for Biomedical Research

Novartis has hired James ‘Jay’ Bradner, from Harvard’s Dana-Farber Cancer Institute, to head its Institutes for Biomedical Research from 1 …

Appointment
Novartis image

Novartis earns provisional NICE yes for Entresto

December 11, 2015
Sales and Marketing Entresto, NICE, Novartis, chronic heart failure, heart failure

NICE has indicated it is likely to recommend Entresto, a novel drug manufactured by Novartis, as a treatment option for …

News
Coartem dosing

Novartis reaches 300 million free antimalarial treatments

December 9, 2015
Manufacturing and Production, Research and Development Coartem, Novartis, antimalarial treatment, malaria, non-profit

Novartis has reached a delivery milestone of 300 million paediatric antimalarial treatments, having supplied its Coartem dispersible without profit to …

News
Scotland flag

Cancer and MS drugs approved in Scotland

December 9, 2015
Sales and Marketing Celgene, Copaxone, Novartis, SMC, Scottish Medicines Consortium, Tevaq, ceritinib, glatiramer acetate, lenalidomide, lung cancer, multiple myeloma, multiple sclerosis, revlimis, zykadia

The Scottish Medicines Consortium (SMC) has approved three new treatments for lung cancer, multiple sclerosis and multiple myeloma, from Novartis, …

News
Red blood cells

ASH 2015 roundup: Amgen, MorphoSys, Novartis and Roche present new trial data

December 8, 2015
Research and Development Amgen, Cancer, Novartis, Roche, ash, morphosys, oncology

Amgen Amgen presented data from three Phase II trials evaluating Blincyto (blinatumomab) in acute lymphoblastic leukemia (ALL)- a rare and …

News
Novartis image

NICE backtracks on Novartis Farydak decision

December 4, 2015
Medical Communications, Sales and Marketing Farydak, NICE, Novartis, panobinostat

NICE has reversed its earlier decision to reject the Novartis drug Farydak as an NHS treatment for people with multiple …

News
zometa

Cancer drugs prices vary up to 388% between high-income countries

December 4, 2015
Medical Communications, Sales and Marketing Cancer, Drug pricing, Eli Lilly, Genzyme, Lancet, Novartis, oncology

The price of new cancer drugs varies widely between high-income countries in Europe, Australia, and New Zealand, new research published …

News
ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015
Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …

News
EU flag

Novartis and Amgen drugs signed-off by European Commission

November 24, 2015
Manufacturing and Production Amgen, Entresto, European Commission, Novartis, blincyto

The European governing body, the European Commission, has approved the Novartis drug Entresto for heart failure and Amgen’s Blincyto for …

News
FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015
Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …

News
novartissunlight_copy

Novartis misses Q3 forecast with $390m settlement payment, strong dollar

October 27, 2015
Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz

Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …

News
cosentyx_logo

Novartis’ Cosentyx gets European approval for two conditions

October 23, 2015
Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis

The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026